Search

everythinglearnresearchcommunity

for

Search:↓

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

A new mutation in the HJV gene was found in a young woman with juvenile hemochromatosis, causing unusual symptoms like secondary hypothyroidism.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

ZDHHC13 is important for normal liver function and metabolism, affecting mitochondrial activity.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Baricitinib is effective and safe for treating severe alopecia areata.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

JAK inhibitors partially restore scalp bacteria balance in alopecia areata patients.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

GATA6 is important for maintaining and differentiating cells in a key area of human skin.